DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Wendtner CM, Ritgen M, Schweighofer CD, Fingerle-Rowson G, Campe H, Jäger G, Eichhorst B, Busch R, Diem H, Engert A, Stilgenbauer S, Döhner H, Kneba M, Emmerich B, Hallek M. German CLL Study Group (GCLLSG).
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission -experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Leukemia 2004; 18: 1093-1101
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.